Related Experiment Video

Updated: Jun 18, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K

Phase IV Drug Trials With a Canadian Site: A Comparison of Industry-Funded and Non-Industry-Funded Trials

Joel Lexchin1,2, Blue Miaoran Dong3, Aravind Ramanathan4

  • 1School of Health Policy and Management, York University, Toronto, ON, Canada.

International Journal of Health Policy and Management
|August 5, 2024
PubMed

Insights

Industry-funded Phase IV clinical trials are larger, international, and published faster than non-industry-funded trials. However, both show limitations in comprehensive reporting and publication accuracy.

Area of Science:

  • Pharmacovigilance
  • Clinical Trial Design
  • Regulatory Science

Background:

  • Regulatory reforms promote expedited drug marketing, increasing reliance on Phase IV trials.
  • Phase IV trials are crucial for post-market safety and efficacy assurance.
  • Assessing characteristics and publication of Phase IV trials is vital for drug safety monitoring.

Purpose of the Study:

  • To compare industry-funded versus non-industry-funded Phase IV trials in Canada.
  • To evaluate the publication status and reporting timeliness of these trials.
  • To identify potential inaccuracies in clinical trial registries regarding publication data.

Main Methods:

  • Utilized ClinicalTrials.gov data for Phase IV trials (2000-2022) with Canadian sites.
  • Categorized trials by funding source: industry vs. non-industry.
  • Conducted manual literature review to determine publication status and compared reporting timeliness.

Main Results:

  • 864 Phase IV trials completed; 55.6% industry-funded, 44.4% non-industry-funded.
  • Industry trials were larger (204 vs. 70 enrollees), more international (57.7% vs. 9.6%), and reported results sooner (1.21 vs. 1.85 years).
  • Publication rates: 81.8% for industry-funded vs. 65.8% for non-industry-funded; 48 inaccuracies found in ClinicalTrials.gov publication associations.

Conclusions:

  • Industry-funded Phase IV trials exhibit distinct characteristics and higher publication rates.
  • Both industry and non-industry funded trials face institutional limitations in comprehensive reporting.
  • Ensuring accuracy in clinical trial registries and promoting publication of all Phase IV results is essential.
Keywords:
ClinicalTrials.govCompleted TrialsHealth CanadaPharmaceutical IndustryPhase IV TrialsPostmarket Trials

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.7K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.6K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
425